Skip to main navigation
Skip to search
Skip to main content
MD Anderson Cancer Center Home
Help & FAQ
Home
Profiles
Research units
Equipment
Research output
Activities
Prizes
Search by expertise, name or affiliation
Treatment Refractory Metastatic Colorectal Cancer
Ryan Huey
,
Kanwal Raghav
GI Medical Oncology
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Treatment Refractory Metastatic Colorectal Cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Colorectal Neoplasms
100%
trifluridine tipiracil
27%
regorafenib
24%
Immunoconjugates
20%
Therapeutics
20%
Microsatellite Instability
19%
DNA Mismatch Repair
18%
Survival
17%
Neoplasms
15%
Survival Rate
11%
Placebos
10%
Drug Therapy
9%
Pharmaceutical Preparations
6%